Congressional Research Service R44132
Specialty Drugs: Background and Policy Concerns
Source-supplied metadata for version 3, published Aug 3, 2015.
Source-supplied fields
Report metadata
- Identifier
- R44132
- Version
- 3
- Product type
- Reports
- Status
- Archived
- Published
- Aug 3, 2015
- Source updated
- Aug 26, 2026, 9:23 am UTC
Authors: Suzanne M. Kirchhoff
Source topics: FDA Product Regulation & Medical Research, Prescription Drugs, Health & Medical R&D, Medicaid & CHIP, Medicare, Private Health Insurance
Politically.com intentionally does not reproduce the report summary or full text. Use the official Congress.gov links above to read the product in its source context.
Structured Congress.gov references
Related federal bills
- HR 2739Cancer Drug Coverage Parity Act of 2015114th Congress
- S 1566Cancer Drug Coverage Parity Act of 2015114th Congress
- HR 1600Patients' Access to Treatments Act of 2015114th Congress
- S 1488Part D Beneficiary Appeals Fairness Act114th Congress